Endologix (NASDAQ:ELGX) : Traders are bullish on Endologix (NASDAQ:ELGX) as it has outperformed the S&P 500 by a wide margin of 10.52% in the past 4 weeks. The bullishness in the stock continues even in the near-term as the stock has returned an impressive 11.94%, relative to the S&P 500. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 13.38% in the last 1 week, and is up 12.3% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock.
The company shares have dropped -7.23% from its 1 Year high price. On Jul 15, 2015, the shares registered one year high at $15.53 and the one year low was seen on Feb 9, 2016. The 50-Day Moving Average price is $12.65 and the 200 Day Moving Average price is recorded at $10.04.
The stock has recorded a 20-day Moving Average of 13.1% and the 50-Day Moving Average is 16.59%.
Endologix (NASDAQ:ELGX): stock turned positive on Friday. Though the stock opened at $13.76, the bulls momentum made the stock top out at $14.27 level for the day. The stock recorded a low of $13.73 and closed the trading day at $14.24, in the green by 3.94%. The total traded volume for the day was 1,310,451. The stock had closed at $13.7 in the previous days trading.
In an insider trading activity, The Securities and Exchange Commission has divulged that Waller Gregory D, director of Endologix Inc /De/, had unloaded 7,800 shares at an average price of $12.86 in a transaction dated on June 3, 2016. The total value of the transaction was worth $100,308.
Endologix, Inc. is engaged in developing, manufacturing, marketing and selling medical devices for the treatment of aortic disorders. The Companys products are intended for the treatment of abdominal aortic aneurysms (AAA). The AAA products are built on one of two platforms: traditional minimally invasive endovascular repair (EVAR) or endovascular sealing (EVAS), its solution for sealing the aneurysm sac while maintaining blood flow through two blood flow lumens. The EVAR products include the Endologix AFX Endovascular AAA System (AFX) and the Endologix Powerlink with Intuitrak Delivery System (Intuitrak). The Companys EVAS product is based on the Nellix platform to seal the aneurysm and provide blood flow to the legs through two blood lumens.